Charles Schwab’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.7M | Buy |
178,104
+13,996
| +9% | +$134K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $1.53M | Sell |
164,108
-6,492
| -4% | -$60.4K | ﹤0.01% | 2701 |
|
|
2024
Q4 | $2.37M | Sell |
170,600
-3,137
| -2% | -$43.6K | ﹤0.01% | 2622 |
|
|
2024
Q3 | $4.08M | Buy |
173,737
+3,792
| +2% | +$89.2K | ﹤0.01% | 2472 |
|
|
2024
Q2 | $2.72M | Buy |
169,945
+17,733
| +12% | +$284K | ﹤0.01% | 2594 |
|
|
2024
Q1 | $2.5M | Buy |
152,212
+41,675
| +38% | +$683K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $1.53M | Buy |
110,537
+323
| +0.3% | +$4.47K | ﹤0.01% | 2690 |
|
|
2023
Q3 | $1.52M | Buy |
110,214
+5,557
| +5% | +$76.5K | ﹤0.01% | 2671 |
|
|
2023
Q2 | $1.78M | Buy |
104,657
+2,287
| +2% | +$38.9K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $1.65M | Buy |
102,370
+3,867
| +4% | +$62.1K | ﹤0.01% | 2574 |
|
|
2022
Q4 | $749K | Buy |
98,503
+2,328
| +2% | +$17.7K | ﹤0.01% | 2879 |
|
|
2022
Q3 | $846K | Buy |
96,175
+14,874
| +18% | +$131K | ﹤0.01% | 2839 |
|
|
2022
Q2 | $582K | Buy |
81,301
+845
| +1% | +$6.05K | ﹤0.01% | 3014 |
|
|
2022
Q1 | $861K | Buy |
80,456
+1,109
| +1% | +$11.9K | ﹤0.01% | 2908 |
|
|
2021
Q4 | $1.12M | Buy |
+79,347
| New | +$1.12M | ﹤0.01% | 2865 |
|